Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus
- PMID: 23956438
- PMCID: PMC3883162
- DOI: 10.1093/infdis/jit433
Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus
Abstract
Interferon lambda 4 protein can be generated in IFNL4-ΔG carriers but not IFNL4-TT homozygotes. We studied 890 anti-hepatitis C virus (HCV)-positive participants in the Women's Interagency HIV Study. Among blacks (n = 555), HCV was more often cleared for those with genotype IFNL4-TT/TT (32.6%; odds ratio [OR], 3.59; P = 3.3 × 10(-5)) than IFNL4-TT/ΔG (11.3%; OR, 0.95; P = .86) or IFNL4-ΔG/ΔG (11.9%; referent). Pooling these data with published results in blacks (n = 1678), ORs were 3.84 (P = 8.6 × 10(-14)) for IFNL4-TT/TT and 1.44 (P = .03) IFNL4-TT/ΔG, and the area under the curve was 0.64 for IFNL4-ΔG genotype and 0.61 for rs12979860 (IL28B). IFNL4-ΔG is strongly associated with impaired spontaneous HCV clearance.
Keywords: HCV; IFNL4; IL28B; genetic; viral clearance.
References
-
- National Institutes of Health Consensus Development Conference statement: management of hepatitis C 2002 (June 10–12, 2002) Gastroenterology. 2002;123:2082–99. - PubMed
-
- Mohd Hanafiah K. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333–42. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UO1-HD-32632/HD/NICHD NIH HHS/United States
- R37 DA004334/DA/NIDA NIH HHS/United States
- UO1-AI-34994/AI/NIAID NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- R01 DA012109/DA/NIDA NIH HHS/United States
- R01 DA004334/DA/NIDA NIH HHS/United States
- DA04334/DA/NIDA NIH HHS/United States
- R01 DA016159/DA/NIDA NIH HHS/United States
- U01-AI-35004/AI/NIAID NIH HHS/United States
- R01-DA13245/DA/NIDA NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- DA12568/DA/NIDA NIH HHS/United States
- UO1-AI-42590/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- UO1-AI-31834/AI/NIAID NIH HHS/United States
- UO1-AI-34989/AI/NIAID NIH HHS/United States
- R56 DA004334/DA/NIDA NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- R01 DA033541/DA/NIDA NIH HHS/United States
- R01-DA16159/DA/NIDA NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- R01 DA013245/DA/NIDA NIH HHS/United States
- P30 DK026743/DK/NIDDK NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- R01 DA009532/DA/NIDA NIH HHS/United States
- UO1-AI-34993/AI/NIAID NIH HHS/United States
- R56 DA012568/DA/NIDA NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- N01 CO012400/CA/NCI NIH HHS/United States
- R01-DA09532/DA/NIDA NIH HHS/United States
- R01 DA012568/DA/NIDA NIH HHS/United States
- N01-CO-12400/CO/NCI NIH HHS/United States
- DA033541/DA/NIDA NIH HHS/United States
- N02-CP-91027/CP/NCI NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
